文献速递关节外科骨质疏松与代谢性骨病

糖尿病与全膝关节置换术后关节纤维化风险增加相关

Diabetes is Associated with an Increased Risk of Arthrofibrosis Following Total Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2026-08-24

该回顾性队列研究基于医疗数据库分析2006至2026年接受初次全膝关节置换术(TKA)的患者,按术前糖化血红蛋白(HbA1c)分层并倾向评分匹配。结果显示,与无糖尿病对照(HbA1c<5.7)相比,HbA1c 5.7–6.9、7.0–7.9及≥8.0组术后3个月内需麻醉下手法松解(MUA)或关节镜下粘连松解(aLOA)的比值比(OR)分别为1.21、1.65和1.91,但3–12个月及>12个月无显著差异。结论认为糖尿病与TKA术后3个月内关节纤维化风险增加相关,且HbA1c越高早期风险越高。

要点

  • 术前HbA1c 5.7–6.9者术后3个月内MUA或aLOA风险轻度升高(OR 1.21)。
  • HbA1c 7.0–7.9和≥8.0者术后3个月内风险进一步升高(OR 1.65和1.91)。
  • 3–12个月及>12个月随访未见显著差异,>12个月分析受事件数抑制限制。

核心结论

  • 糖尿病与全膝关节置换术后3个月内需MUA或aLOA的关节纤维化风险增加相关。
  • 术前HbA1c水平越高,术后早期关节纤维化风险呈进行性升高。

研究设计与样本

  • 回顾性队列分析,使用医疗数据库识别2006至2026年间接受初次TKA的患者。
  • 按术前HbA1c分为良好控制(5.7–6.9)、中度未控制(7.0–7.9)、严重未控制(≥8.0)及无糖尿病对照(<5.7),并进行倾向评分匹配。

主要发现

  • 与对照相比,HbA1c 5.7–6.9组术后3个月内MUA或aLOA的OR为1.21(95%CI 1.07–1.37)。
  • HbA1c 7.0–7.9组术后3个月内OR为1.65(95%CI 1.37–1.97)。
  • HbA1c≥8.0组术后3个月内OR最高,为1.91(95%CI 1.35–2.71)。
  • 3–12个月及>12个月各HbA1c组与对照相比均无显著差异;>12个月分析因事件数抑制受限。

关键数值与推荐

  • 术前HbA1c分层界值:良好控制5.7–6.9,中度未控制7.0–7.9,严重未控制≥8.0,无糖尿病对照<5.7。
  • 结局指标为术后<3个月、3–12个月及>12个月需MUA或aLOA的率。

临床怎么用

  • 对TKA术前HbA1c≥5.7的患者,尤其≥7.0者,应关注术后3个月内关节纤维化风险。
  • 优化术前血糖控制可能有助于降低早期MUA或aLOA风险。

局限性

  • 回顾性数据库分析可能存在未测量混杂。
  • >12个月分析因事件数抑制而受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The relationship between diabetes and arthrofibrosis following total knee arthroplasty (TKA) remains unclear. This study evaluated whether varying levels of preoperative glycemic control, measured by hemoglobin A1c (HbA1c), are associated with arthrofibrosis requiring manipulation under anesthesia (MUA) or arthroscopic lysis of adhesions (aLOA) after TKA. METHODS: A retrospective cohort analysis of a healthcare database identified patients who underwent primary TKA between 2006 and 2026. Patients were stratified by preoperative HbA1c: well-controlled (5.7 to 6.9), moderately uncontrolled (7.0 to 7.9), severely uncontrolled (≥ 8.0), and non-diabetic controls (less than 5.7). Propensity score-matched cohorts were assessed for MUA or aLOA rates at less than three months, three to 12 months, and greater than 12 months postoperatively. RESULTS: Compared with controls, patients who had HbA1c 5.7 to 6.9 had increased odds of MUA or aLOA within three months after TKA (odds ratio (OR) 1.21, 95% confidence interval (CI) 1.07 to 1.37), with no significant differences at three to 12 months or greater than 12 months. Patients who had HbA1c 7.0 to 7.9 demonstrated greater early risk within three months (OR 1.65, 95% CI 1.37 to 1.97), without significant differences at later time points. Patients who had HbA1c ≥ 8.0 demonstrated the highest early risk within three months (OR 1.91, 95% CI 1.35 to 2.71), with no significant difference at three to 12 months; analysis beyond 12 months was limited by suppressed event counts. CONCLUSION: Diabetes is associated with an increased risk of arthrofibrosis requiring MUA or aLOA within three months following TKA. Increasing HbA1c levels correlated with progressively higher early arthrofibrosis risk. These findings suggest that worse preoperative glycemic control is associated with an elevated risk of early postoperative arthrofibrosis following TKA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hall RP, Braithwaite CL, Van Schuyver PR, et al. Diabetes is Associated with an Increased Risk of Arthrofibrosis Following Total Knee Arthroplasty. J Arthroplasty. 2026. PMID: 42637016. doi:10.1016/j.arth.2026.08.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。